Beat Thürlimann

1994–2025 年に発表

75
論文数
28,709
被引用数
66
h 指数
74
i10 指数

被引用数

Beat Thürlimann の年別被引用数1974 年: 被引用 2 件1980 年: 被引用 1 件1981 年: 被引用 1 件1996 年: 被引用 5 件1997 年: 被引用 7 件1998 年: 被引用 9 件1999 年: 被引用 10 件2000 年: 被引用 16 件2001 年: 被引用 39 件2002 年: 被引用 38 件2003 年: 被引用 64 件2004 年: 被引用 74 件2005 年: 被引用 108 件2006 年: 被引用 97 件2007 年: 被引用 140 件2008 年: 被引用 173 件2009 年: 被引用 194 件2010 年: 被引用 176 件2011 年: 被引用 192 件2012 年: 被引用 188 件2013 年: 被引用 216 件2014 年: 被引用 184 件2015 年: 被引用 198 件2016 年: 被引用 217 件2017 年: 被引用 218 件2018 年: 被引用 193 件2019 年: 被引用 733 件2020 年: 被引用 840 件2021 年: 被引用 662 件2022 年: 被引用 544 件2023 年: 被引用 410 件2024 年: 被引用 600 件2025 年: 被引用 259 件2026 年: 被引用 7 件1975〜1979 年は被引用が無いため表示していません1982〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,817 件、この内訳の 18%中国: 引用元論文 970 件、この内訳の 9.6%イタリア: 引用元論文 752 件、この内訳の 7.5%イギリス: 引用元論文 656 件、この内訳の 6.5%ドイツ: 引用元論文 542 件、この内訳の 5.4%フランス: 引用元論文 358 件、この内訳の 3.6%スイス: 引用元論文 342 件、この内訳の 3.4%カナダ: 引用元論文 314 件、この内訳の 3.1%オランダ: 引用元論文 307 件、この内訳の 3.1%ベルギー: 引用元論文 302 件、この内訳の 3%オーストラリア: 引用元論文 299 件、この内訳の 3%スペイン: 引用元論文 273 件、この内訳の 2.7%
0%18%その他 31.1%

分野

  • Biochemistry, Genetics and Molecular Biology51.2%
  • Medicine40.7%
  • Computer Science2.4%
  • Immunology and Microbiology1.1%
  • Engineering1%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • その他2.9%

トピック

  • Breast Cancer Treatment Studies15.3%
  • Breast Lesions and Carcinomas5.6%
  • HER2/EGFR in Cancer Research4.7%
  • Estrogen and related hormone effects4.5%
  • Advanced Breast Cancer Therapies3.6%
  • Cancer Cells and Metastasis2.5%
  • その他63.8%

共著者

全論文

検索で開く
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  2. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  3. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

    著者: , , , , , - Annals of Oncology 2011 被引用: 3,881

  4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  5. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221

  6. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 被引用: 1,255

  7. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 623

  8. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

    著者: , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 690

  9. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 497

  10. Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 253

  11. Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5

    著者: , , , , , , , - Journal of Clinical Oncology 2018 被引用: 189

  12. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 199

  13. Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 133

  14. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

    著者: , , , , , - Annals of Oncology 2009 被引用: 1,370

  15. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 408

  16. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 206

  17. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98

    著者: , , , , , , , , , , , , - Breast Cancer Research 2019 被引用: 148

  18. Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 136

  19. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Colleoni, Alan S. Coates, Aron Goldhirsch, Gini F. Fleming, Prudence A. Francis, Terence P. Speed, Meredith M. Regan, Sherene Loi - Annals of Oncology 2023 被引用: 48

  20. Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 456

  21. The multidisciplinary meeting: An indispensable aid to communication between different specialities

    著者: , , , - European Journal of Cancer 2006 被引用: 297

  22. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

    著者: , , , , , , , , , , , , , , , , , - Annals of Oncology 2009 被引用: 185

  23. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 167

  24. Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 76